scholarly journals Faculty Opinions recommendation of Proactive therapeutic drug monitoring of adalimumab is associated with better long-term outcomes compared to standard of care in patients with inflammatory bowel disease.

2019 ◽  
Author(s):  
Sara McCartney
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Standard Of Care ◽  
Therapeutic Drug ◽  
Long Term Outcomes ◽  
Inflammatory Bowel

Long-Term Outcomes of Proactive Versus Reactive Therapeutic Drug Monitoring for Optimizing Infliximab Therapy in Inflammatory Bowel Disease

2017 ◽  
Vol 152 (5) ◽  
pp. S381-S382
Author(s):  
Konstantinos Papamichail ◽  
Karen A. Chachu ◽  
Ravy K. Vajravelu ◽  
Byron P. Vaughn ◽  
Josephine Ni ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Infliximab Therapy ◽  
Therapeutic Drug ◽  
Long Term Outcomes ◽  
Inflammatory Bowel

Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease

2020 ◽  
Vol 65 (4) ◽  
Author(s):  
Daniela Pugliese ◽  
Giuseppe Privitera ◽  
Fabrizio Pizzolante ◽  
Antonio Gasbarrini ◽  
Luisa Guidi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel

scholarly journals P546 Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S387-S387
Author(s):  
N Torres ◽  
D Martín Arranz ◽  
M Sánchez Azofra ◽  
E Martín Arranz ◽  
L Garcia ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Therapeutic Drug Monitoring ◽  
Bowel Disease ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document